Skip to content
Screener

Astrana Health ASTH Q2 2025 earnings

Reported August 7, 2025 · After market close

Revenue$654.8MMiss by $288.9M
EPS$0.19Miss by $0.17
Revenue estimate$943.7M
EPS estimate$0.36

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$1.0B
EPS estimate$0.42

Financials

Q2 2025

Income statement

See full
Revenue$654.8M+34.7%
Gross profit$78.0M+6.1%
Operating income$20.3M-32.3%
Net income$9.4M-50.8%
EPS (diluted)$0.19-52.5%

Balance sheet

See full
Cash & equivalents$339.7M+4.4%
Total debt$447.6M-5.9%
Total equity$765.5M+12.8%
Total assets$1.4B+15.2%

Cash flow

See full
Operating cash flow$90.9M+292%
CapEx$1.4M-49.9%
Free cash flow$89.5M+340%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.23B-36.5%
Enterprise value$1.34B-35.9%
P/S0.5×-0.7×

Profitability

See full
Gross margin11.3%-5.0pp
Operating margin2.9%-3.3pp

Returns & leverage

See full
Debt / equity0.6×-0.1×
Current ratio1.6×-0.3×

Segments

By product

See full
Health Care Patient Service$17.9M-10.4%
Health Care Other$15.4M-16.3%
Management Service$2.6M+60.7%

FAQ

When did Astrana Health report Q2 2025 earnings?
Astrana Health (ASTH) reported Q2 2025 earnings on August 7, 2025 after market close.
What were Astrana Health's Q2 2025 revenue and EPS?
Astrana Health reported revenue of $654.8M and eps of $0.19 for Q2 2025.
Did Astrana Health beat estimates in Q2 2025?
Revenue missed the consensus estimate of $943.7M by $288.9M. EPS missed the consensus estimate of $0.36 by $0.17.
How did Astrana Health's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 34.7% from $486.3M a year earlier and eps declined 52.5% from $0.40.
Where can I find Astrana Health's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-075194) and the 10-Q periodic report (0000950170-25-105242) directly on SEC EDGAR. The filing index links above go to sec.gov.